TRL1068: Clinical Trials

4 trials of TRL1068, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 active not recruiting, 1 completed, 1 not yet recruiting, 1 unknown. 3 Phase 1, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 13Completed 1, Not yet recruiting 1, Unknown 1
Phase 21Active not recruiting 1

Follow TRL1068: new trials by email Literature Review of TRL1068 trials Research Report on TRL1068

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Study to Evaluate Safety and Activity of Inhaled TRL1068 in Healthy Volunteers
TRL1068, a human monoclonal antibody - Healthy Volunteer
Phase 1Not yet recruitingTrellis Bioscience LLC142026-10-012026-06-12
Study to Evaluate the Efficacy and Safety of TRL1068 for the Treatment of Prosthetic Joint Infection
TRL1068 (calpurbatug), a human monoclonal antibody, DAIR - Prosthetic Joint Infections of Hip, Prosthetic Joint Infections of Knee
Phase 2Active not recruitingTrellis Bioscience LLC602025-04-082026-05-07
Study to Evaluate Safety and Activity of TRL1068 in Chronic Rhinosinusitis
TRL1068 - Chronic Rhinosinusitis With Nasal Polyps
Phase 1UnknownTrellis Bioscience LLC122024-01-012023-04-12
Study to Evaluate Safety and Activity of TRL1068 in Prosthetic Joint Infections
TRL1068, a human monoclonal antibody - Prosthetic Joint Infection
Phase 1CompletedTrellis Bioscience LLC152021-02-082024-11-21

Sponsors

Trellis Bioscience LLC (4)

Countries

United States (3)

Top investigators

Daniel Oakes, MD (1)  ·  Edward Stolarski, MD (1)  ·  Ian Duensing, MD (1)  ·  Janet Conway, MD (1)  ·  Luis Pulido, MD (1)  ·  Nicholas Bernthal, MD (1)  ·  Richard Berkowitz, MD (1)  ·  Sameer Naranje, MD (1)  ·  Stephen Incavo, MD (1)

Results publications

PMID 39012102